Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study.

Landy DC, Miller TL, Lipsitz SR, Lopez-Mitnik G, Hinkle AS, Constine LS, Adams MJ, Lipshultz SE.

Pediatr Cardiol. 2013 Apr;34(4):826-34. doi: 10.1007/s00246-012-0539-6. Epub 2012 Oct 19.

2.

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.

Leger K, Slone T, Lemler M, Leonard D, Cochran C, Bowman WP, Bashore L, Winick N.

Pediatr Blood Cancer. 2015 Jan;62(1):123-7. doi: 10.1002/pbc.25206. Epub 2014 Aug 30.

PMID:
25176022
3.

Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.

Lipshultz SE, Landy DC, Lopez-Mitnik G, Lipsitz SR, Hinkle AS, Constine LS, French CA, Rovitelli AM, Proukou C, Adams MJ, Miller TL.

J Clin Oncol. 2012 Apr 1;30(10):1050-7. doi: 10.1200/JCO.2010.33.7907. Epub 2012 Mar 5.

4.

Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.

Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S.

Clin Cancer Res. 2014 Dec 15;20(24):6314-23. doi: 10.1158/1078-0432.CCR-13-3490. Epub 2014 Jun 19.

5.

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.

Sieswerda E, van Dalen EC, Postma A, Cheuk DK, Caron HN, Kremer LC.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008011. doi: 10.1002/14651858.CD008011.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD008011.

PMID:
21901716
6.

Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.

Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B.

J Cancer Surviv. 2012 Mar;6(1):95-101. doi: 10.1007/s11764-011-0186-6. Epub 2011 Jun 1.

7.

Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion.

Yildirim A, Sedef Tunaoglu F, Pinarli FG, Ilhan M, Oguz A, Karadeniz C, Olguntürk R, Oguz D, Kula S.

Eur J Echocardiogr. 2010 Dec;11(10):814-22. doi: 10.1093/ejechocard/jeq071. Epub 2010 Jun 19.

PMID:
20562426
8.

Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.

Toro-Salazar OH, Gillan E, O'Loughlin MT, Burke GS, Ferranti J, Stainsby J, Liang B, Mazur W, Raman SV, Hor KN.

Circ Cardiovasc Imaging. 2013 Nov;6(6):873-80. doi: 10.1161/CIRCIMAGING.113.000798. Epub 2013 Oct 4.

9.

Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.

Dietz AC, Sivanandam S, Konety S, Kaufman CL, Gage RM, Kelly AS, Neglia JP, Mulrooney DA.

J Cancer Surviv. 2014 Jun;8(2):183-9. doi: 10.1007/s11764-013-0326-2. Epub 2013 Dec 7.

10.

Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.

Sieswerda E, Kremer LC, Vidmar S, De Bruin ML, Smibert E, Sjöberg G, Cheung MM, Weintraub RG.

Pediatr Blood Cancer. 2010 Apr;54(4):579-84. doi: 10.1002/pbc.22371.

PMID:
20014238
11.

Cardiac function in Wilms' tumor survivors.

Sorensen K, Levitt G, Sebag-Montefiore D, Bull C, Sullivan I.

J Clin Oncol. 1995 Jul;13(7):1546-56.

PMID:
7602343
12.

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.

Mladosievicova B, Urbanova D, Radvanska E, Slavkovsky P, Simkova I.

J Exp Clin Cancer Res. 2012 Oct 11;31:86. doi: 10.1186/1756-9966-31-86.

13.

Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography.

Ryerson AB, Border WL, Wasilewski-Masker K, Goodman M, Meacham L, Austin H, Mertens AC.

Pediatr Blood Cancer. 2015 Mar;62(3):502-8. doi: 10.1002/pbc.25328. Epub 2014 Nov 12.

PMID:
25393686
14.

Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?

Ramjaun A, AlDuhaiby E, Ahmed S, Wang L, Yu E, Nathan PC, Hodgson DC.

Pediatr Blood Cancer. 2015 Dec;62(12):2197-203. doi: 10.1002/pbc.25651. Epub 2015 Jul 6. Erratum in: Pediatr Blood Cancer. 2017 Mar;64(3):.

15.

Cardiac changes associated with growth hormone therapy among children treated with anthracyclines.

Lipshultz SE, Vlach SA, Lipsitz SR, Sallan SE, Schwartz ML, Colan SD.

Pediatrics. 2005 Jun;115(6):1613-22.

PMID:
15930224
16.

Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia.

Christiansen JR, Kanellopoulos A, Lund MB, Massey R, Dalen H, Kiserud CE, Ruud E, Aakhus S.

Pediatr Blood Cancer. 2015 Aug;62(8):1437-43. doi: 10.1002/pbc.25492. Epub 2015 Apr 1.

PMID:
25832752
17.

Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors.

Amigoni M, Giannattasio C, Fraschini D, Galbiati M, Capra AC, Madotto F, Cesana F, Jankovic M, Masera G, Mancia G.

Pediatr Blood Cancer. 2010 Dec 15;55(7):1343-7. doi: 10.1002/pbc.22637.

PMID:
20589666
18.

Pediatric quality of life in long-term survivors of childhood cancer treated with anthracyclines.

Ryerson AB, Wasilewski-Masker K, Border WL, Goodman M, Meacham L, Austin H, Marchak JG, Mertens AC.

Pediatr Blood Cancer. 2016 Dec;63(12):2205-2211. doi: 10.1002/pbc.26149. Epub 2016 Jul 21.

PMID:
27442487
19.

[The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline].

Yildirim A, Tunaoğlu FS, Pinarli FG, Ilhan M, Oğuz A, Karadeniz C, Olguntürk R, Oğuz D, Kula S.

Anadolu Kardiyol Derg. 2010 Apr;10(2):154-62. doi: 10.5152/akd.2010.042. Turkish.

20.

Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?

Pourier MS, Mavinkurve-Groothuis AM, Loonen J, Bökkerink JP, Roeleveld N, Beer G, Bellersen L, Kapusta L.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26243. Epub 2016 Sep 21.

PMID:
27654133

Supplemental Content

Support Center